South Korea · Delayed Price · Currency is KRW OPTUS Pharmaceutical Statistics
Total Valuation
KOSDAQ:131030 has a market cap or net worth of KRW 190.58 billion. The enterprise value is 151.76 billion.
| Market Cap | 190.58B |
| Enterprise Value | 151.76B |
Important Dates
The last earnings date was Friday, January 23, 2026.
| Earnings Date | Jan 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:131030 has 17.65 million shares outstanding. The number of shares has increased by 1.88% in one year.
| Current Share Class | 17.65M |
| Shares Outstanding | 17.65M |
| Shares Change (YoY) | +1.88% |
| Shares Change (QoQ) | +7.03% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 3.78% |
| Float | 11.02M |
Valuation Ratios
The trailing PE ratio is 14.79.
| PE Ratio | 14.79 |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.17, with an EV/FCF ratio of -5.36.
| EV / Earnings | 13.36 |
| EV / Sales | 1.74 |
| EV / EBITDA | 11.17 |
| EV / EBIT | 17.10 |
| EV / FCF | -5.36 |
Financial Position
The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.62 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | -0.03 |
| Interest Coverage | 127.99 |
Financial Efficiency
Return on equity (ROE) is 7.36% and return on invested capital (ROIC) is 7.20%.
| Return on Equity (ROE) | 7.36% |
| Return on Assets (ROA) | 3.10% |
| Return on Invested Capital (ROIC) | 7.20% |
| Return on Capital Employed (ROCE) | 5.36% |
| Weighted Average Cost of Capital (WACC) | 6.71% |
| Revenue Per Employee | 548.18M |
| Profits Per Employee | 71.43M |
| Employee Count | 159 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | -305.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +79.40% in the last 52 weeks. The beta is 0.45, so KOSDAQ:131030's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +79.40% |
| 50-Day Moving Average | 10,431.40 |
| 200-Day Moving Average | 7,862.65 |
| Relative Strength Index (RSI) | 44.97 |
| Average Volume (20 Days) | 994,957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:131030 had revenue of KRW 87.16 billion and earned 11.36 billion in profits. Earnings per share was 730.00.
| Revenue | 87.16B |
| Gross Profit | 48.12B |
| Operating Income | 8.88B |
| Pretax Income | 11.05B |
| Net Income | 11.36B |
| EBITDA | 13.58B |
| EBIT | 8.88B |
| Earnings Per Share (EPS) | 730.00 |
Balance Sheet
The company has 39.80 billion in cash and 972.44 million in debt, with a net cash position of 38.82 billion or 2,200.07 per share.
| Cash & Cash Equivalents | 39.80B |
| Total Debt | 972.44M |
| Net Cash | 38.82B |
| Net Cash Per Share | 2,200.07 |
| Equity (Book Value) | 165.01B |
| Book Value Per Share | 10,138.60 |
| Working Capital | 41.55B |
Cash Flow
In the last 12 months, operating cash flow was 16.23 billion and capital expenditures -44.51 billion, giving a free cash flow of -28.29 billion.
| Operating Cash Flow | 16.23B |
| Capital Expenditures | -44.51B |
| Depreciation & Amortization | 4.71B |
| Net Borrowing | -751.86M |
| Free Cash Flow | -28.29B |
| FCF Per Share | -1,603.13 |
Margins
Gross margin is 55.21%, with operating and profit margins of 10.18% and 13.03%.
| Gross Margin | 55.21% |
| Operating Margin | 10.18% |
| Pretax Margin | 12.68% |
| Profit Margin | 13.03% |
| EBITDA Margin | 15.58% |
| EBIT Margin | 10.18% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:131030 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.88% |
| Shareholder Yield | -1.88% |
| Earnings Yield | 5.96% |
| FCF Yield | -14.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:131030 has an Altman Z-Score of 4.27 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.27 |
| Piotroski F-Score | 5 |